Overview

Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This study aims to compare azathioprine versus mesalazine tablets for the prevention of clinical relapse in postoperative Crohn's disease (CD) patients with moderate or severe endoscopic recurrence.
Phase:
Phase 3
Details
Lead Sponsor:
Dr. Falk Pharma GmbH
Treatments:
Azathioprine
Mesalamine